AI Drug Interaction Analysis System for Side Effect Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing drug-drug interactions (DDI) are inefficient, requiring significant time, human, and material resources, and lack comprehensive data for evaluating the safety and efficacy of combined drug administration due to the complexity of pharmacokinetic and pharmacodynamic interactions among the numerous existing drugs.
Innovation Solution
A method and device utilizing an artificial intelligence algorithm that preprocesses data sets for chemical structures, side effect grades, and types to train AI models, determining the grade and type of side effects between drug pairs by generating detailed attribute information and normalizing expressions, thereby predicting suitable drug combinations for combination therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional methods are used to analyze drug-drug interactions, then comprehensive evaluation of safety and efficacy can be achieved, but significant time, human, and material resources are consumed
Solution Approach 1:
The patent replaces traditional manual pharmacokinetic and pharmacodynamic analysis methods with an artificial intelligence-based system. The AI model automatically processes drug interaction data, predicting side effect grades and types without requiring extensive human expert intervention, thereby reducing time and resource consumption while maintaining evaluation completeness.
Solution Approach 2:
The patent transforms the analysis approach by changing from manual parameter evaluation to automated AI-based prediction. The system uses machine learning algorithms to process and interpret drug interaction parameters, converting complex manual analysis into automated computational processing that achieves both speed and comprehensiveness.
2Measurement precision
If comprehensive data collection for all drug combinations is performed, then accurate DDI prediction is achieved, but the complexity and resource consumption increase significantly
Solution Approach 1:
The patent extracts and focuses on the most critical factors for drug interaction prediction from the vast amount of available data. By identifying and prioritizing key pharmacokinetic and pharmacodynamic parameters, the system achieves accurate predictions without needing to process every possible data point, thereby reducing system complexity while maintaining precision.
Solution Approach 2:
The patent segments the drug interaction analysis into distinct components: pharmacokinetic interactions, pharmacodynamic interactions, and side effect prediction. This segmentation allows the AI system to handle complex data in manageable portions, improving prediction accuracy while reducing overall system complexity through modular processing.
3Loss of information
If manual analysis of pharmacokinetic and pharmacodynamic interactions is performed, then detailed interaction evaluation is achieved, but human resources and time consumption increase
Solution Approach 1:
The AI system performs self-service analysis by automatically processing and interpreting drug interaction data without requiring continuous human intervention. The model independently evaluates pharmacokinetic and pharmacodynamic interactions, generating detailed interaction evaluations that would otherwise require significant human expertise and time investment.
Solution Approach 2:
The patent replaces manual pharmacokinetic and pharmacodynamic analysis with automated AI-based evaluation mechanisms. The system uses machine learning algorithms to process interaction data and generate detailed evaluations, substituting human expert analysis with computational methods that maintain information completeness while dramatically improving productivity.
Data Source
AI summary
A method for analyzing drug-drug interaction includes: acquiring a first data set for chemical structures of drugs, a second data set for a grade of a side effect between the drugs and a third data set for a type of a side effect between the drugs, generating detailed attribute information of each of the drugs, by preprocessing the first data set, standardizing a class included in the second data set and giving directionality, by preprocessing the second data set, extracting expressions representing a side effect type included in the third data set, normalizing the expressions and giving directionality to the third data set, by preprocessing the third data set, training at least one artificial intelligence model using the preprocessed first, second, and the third data set, and determining the grade and type of the side effect of a pair of drugs using the at least one artificial intelligence model.